Table 2 Additional agents used for reversal of INR §
From: Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
Reversal administration | n = 58 |
|---|---|
Received vitamin K only (n, %) | 7, 12% |
Received FFP ∆ only (n, %) | 14, 24% |
Received both vitamin K and FFP (n, %)) | 35, 60% |